An association study of 45 folate-related genes in spina bifida: Involvement of Cubilin (CUBN) and tRNA Aspartic Acid Methyltransferase 1 (TRDMT1)

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 85, Issue 3, 2009, Pages 216-226

  Franke, Barbara ^a   Vermeulen, Sita H H M ^a   Steegers Theunissen, Regine P M ^a,b   Coenen, Marieke J ^a   Schijvenaars, Mascha M V A P ^a   Scheffer, Hans ^a   Den Heijer, Martin ^a   Blom, Henk J ^a,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Case control studies; Cobalamin; Folic acid; Homocysteine; Neural tube defects; Relative risk; Single nucleotide polymorphism; SNP

Indexed keywords

CUBILIN; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHYLTRANSFERASE; TRANSFER RNA; TRANSFER RNA ASPARTIC ACID METHYLTRANSFERASE 1; UNCLASSIFIED DRUG;

AMINO ACID BLOOD LEVEL; ARTICLE; CELL LEVEL; CONTROLLED STUDY; DEVELOPMENTAL GENE; ERYTHROCYTE; FOLATE METABOLISM; FOLIC ACID BLOOD LEVEL; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPINA BIFIDA; VITAMIN BLOOD LEVEL;

CHILD; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; FEMALE; FOLIC ACID; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, CELL SURFACE; SPINAL DYSRAPHISM;

EID: 62949117622     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20556     Document Type: Article

References (33)

1. Anthony TE, Heintz N. 2007. The folate metabolic enzyme ALDH1L1 is restricted to the midline of the early CNS, suggesting a role in human neural tube defects. J Comp Neurol 500:368-383.
2. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 57:289-300.
3. Berry RJ, Li Z. 2002. Folic acid alone prevents neural tube defects: evidence from the China study. Epidemiology 13:114-116.
4. Blom HJ, Shaw GM, den Heijer M, Finnell RH. 2006. Neural tube defects and folate: case far from closed. Nat Rev Neurosci 7:724-731.
5. Christensen EI, Birn H. 2002. Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol 3:256-266.
6. Cleves MA. 1999. Hardy-Weinberg equilibrium tests and allele frequency estimation. Stata Technical Bulletin 48:34-37.
7. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation N Engl J Med 327:1832-1835.
8. Enaw JO, Zhu H, Yang W, et al. 2006. CHKA and PCYT1A gene polymorphisms, choline intake and spina bifida risk in a California population. BMC Med 4:36.
9. Goll MG, Kirpekar F, Maggert KA, et al. 2006. Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2. Science 311:395-398.
10. Groenen PM, Klootwijk R, Schijvenaars MM, et al. 2004. Spina bifida and genetic factors related to myo-inositol, glucose, and zinc. Mol Genet Metab 82:154-161.
11. Guo SW, Thompson EA. 1992. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48:361-372.
12. den Heijer M, Blom HJ, Gerrits WB, et al. 1995. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet 345:882-885.
13. Klootwijk R, Groenen P, Schijvenaars M, et al. 2004. Genetic variants in ZIC1, ZIC2, and ZIC3 are not major risk factors for neural tube defects in humans. Am J Med Genet A 124:40-47.
14. Lievers KJ, Kluijtmans LA, Heil SG, et al. 2001. A 31 bp VNTR in the cystathionine beta-synthase (CBS) gene is associated with reduced CBS activity and elevated post-load homocysteine levels. Eur J Hum Genet 9:583-589.
15. van der Linden I, Afman LA, Heil SG, Blom HJ. 2006. Genetic variation in genes of folate metabolism and neural-tube defect risk. Proc Nutr Soc 65:204-215.
16. de Marco P, Calevo MG, Moroni A, et al. 2003. Reduced folate carrier polymorphism (80A→G) and neural tube defects. Eur J Hum Genet 11:245-252.
17. Mariman EC, Hamel BC. 1992. Sex ratios of affected and transmitting members of multiple case families with neural tube defects. J Med Genet 29:695-698.
18. Morin I, Devlin AM, Leclerc D, et al. 2003. Evaluation of genetic variants in the reduced folate carrier and in glutamate carboxypeptidase II for spina bifida risk. Mol Genet Metab 79:197-200.
19. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131-137.
20. Newson R. 2003. Multiple-test procedures and smile-plots. The Stata Journal 3:109-132.
21. O'Leary VB, Pangilinan F, Cox C, et al. 2006. Reduced folate carrier polymorphisms and neural tube defect risk. Mol Genet Metab 87:364-369.
22. Pei L, Zhu H, Ren A, et al. 2005. Reduced folate carrier gene is a risk factor for neural tube defects in a Chinese population. Birth Defects Res A Clin Mol Teratol 73:430-433.
23. Purcell S, Daly MJ, Sham PC. 2007. WHAP: haplotype-based association analysis. Bioinformatics 23:255-256.
24. van der Put NM, Steegers-Theunissen RP, Frosst P, et al. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.
25. Ray JG, Blom HJ. 2003. Vitamin B12 insufficiency and the risk of fetal neural tube defects. QJM 96:289-295.
26. Riva A, Kohane IS. 2002. SNPper: retrieval and analysis of human SNPs. Bioinformatics 18:1681-1685.
27. Ruczinski I, Kooperberg C, LeBlanc ML. 2004. Exploring interactions in high-dimensional genomic data: an overview of logic regression, with applications. Journal of Multivariate Analysis 90:178-195.
28. Shaw GM, Lammer EJ, Zhu H, et al. 2002. Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Am J Med Genet 108:1-6.
29. Shaw GM, Carmichael SL, Yang W, et al. 2004. Periconceptional dietary intake of choline and betaine and neural tube defects in offspring. Am J Epidemiol 160:102-109.
30. Sherry ST, Ward MH, Kholodov M, et al. 2001. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29:308-311.
31. Steegers-Theunissen RP, Boers GH, Trijbels FJ, Eskes TK. 1991. Neuraltube defects and derangement of homocysteine metabolism. N Engl J Med 324:199-200.
32. Tonisson N, Kurg A, Kaasik K, et al. 2000. Unravelling genetic data by arrayed primer extension. Clin Chem Lab Med 38:165-170.
33. Vieira AR, Murray JC, Trembath D, et al. 2005. Studies of reduced folate carrier 1 (RFC1) A80G and 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms with neural tube and orofacial cleft defects. Am J Med Genet A 135:220-223.